Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2021 ∙ Santosa, A. Xu, C. Arkachaisri, T. Kong, K. O. Lateef, A. Lee, T. H. Leong, K. H. Low, A. H. L. Sriranganathan, M. K. Tan, T. C. Teng, G. G. Thong, B. Y. Fong, W. Lahiri, M.

Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Jena, Anuraag Mishra, Shubhra Deepak, Parakkal Kumar-M, Praveen Sharma, Aman Patel, Yusuf I. Kennedy, Nicholas A. Kim, Alfred H. J. Sharma, Vishal Sebastian, Shaji

Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Ling, Y. Zhong, J. Luo, J.

Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Fan, Y. J. Chan, K. H. Hung, I. F.

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3

  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Ma, K. S. K. Lee, C. C. Liu, K. J. Wei, J. C. C. Lee, Y. T. Wang, L. T.

Safety and seroconversion of immunotherapies against sars-cov-2 infection: A systematic review and meta-analysis of clinical trials

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Ciapponi, Agustín Bardach, Ariel Mazzoni, Agustina Alconada, Tomás Steven Anderson, A. Argento, Fernando J. Ballivian, Jamile Bok, Karin Comandé, Daniel Erbelding, Emily Goucher, Erin Kampmann, Beate Karron, Ruth Munoz, Flor M. Carolina Palermo, María P. K. Parker, Edward Rodriguez Cairoli, Federico Santa María, Victoria Stergachis, Andy S. Voss, Gerald Xiong, Xu Zamora, Natalia Zaraa, Sabra Berrueta, Mabel Buekens, Pierre M.

Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Chen, M. Yuan, Y. Zhou, Y. Deng, Z. Zhao, J. Feng, F. Zou, H. Sun, C.

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Lv, M. Luo, X. Shen, Q. Lei, R. Liu, X. Liu, E. Li, Q. Chen, Y.

Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Rogliani, P. Chetta, A. Cazzola, M. Calzetta, L.

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Sung, K. Y. Chang, T. E. Wang, Y. P. Lin, C. C. Chang, C. Y. Hou, M. C. Lu, C. L.

SARS-CoV-2 vaccination in patients with inflammatory bowel disease: systemic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...